Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations by Rossi, Isabelle et al.
OBESITY
Sex difference and the role of leptin in the association
between high-sensitivity C-reactive protein and adiposity in two
different populations
Isabelle Anne Rossi • Murielle Bochud •
Pascal Bovet • Fred Paccaud • Ge´rard Waeber •
Peter Vollenweider • Patrick Taffe´
Received: 3 October 2011 / Accepted: 23 February 2012 / Published online: 6 March 2012
 Springer Science+Business Media B.V. 2012
Abstract Elevated high-sensitivity C-reactive protein
(hs-CRP) concentration is associated with an increased risk
of cardiovascular disease but this association seems to be
largely mediated via conventional cardiovascular risk fac-
tors. In particular, the association between hs-CRP and
obesity has been extensively demonstrated and correlations
are stronger in women than men. We used fractional
polynomials—a method that allows flexible modeling of
non linear relations—to investigate the dose/response
mathematical relationship between hs-CRP and several
indicators of adiposity in Caucasians (Switzerland) and
Africans (Seychelles) surveyed in two population-based
studies. This relationship was non-linear exhibiting a
steeper slope for low levels of hs-CRP and a higher level in
women. The observed sex difference in the relationship
between hs-CRP and adiposity almost disappeared upon
adjustment for leptin, suggesting that these sex differences
might be partially mediated, by leptin. All these relation-
ship were similar in Caucasians and Africans. This is the
first report on a non-linear relation, stratified by gender,
between hs-CRP and adiposity.
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Background
C-reactive protein (CRP) is a sensitive but unspecific acute
phase protein, synthesized by the liver. Elevated high
sensitivity CRP (hs-CRP) concentration is associated with
cardiovascular disease [1–6], although this association
largely depends on conventional cardiovascular risk factors
[7]. In particular, hs-CRP level is directly associated with
each single components of the metabolic syndrome [8–10]
and predicts the development of the full syndrome [11].
The association between hs-CRP and adiposity has also
been extensively documented [9, 12, 13] especially with
central abdominal adiposity [14, 15].
Correlations between hs-CRP and adiposity are stronger
in women than men [14, 16–20]. This sex difference is also
found in a Mendelian randomization analysis, suggesting a
causal association in women but not in men [21]. Such a
causal relationship was however not confirmed by other
authors [22–24].
Given the paucity of available data regarding hs-CRP
distribution in African populations and the increasing
interest in hs-CRP for cardiovascular risk prediction, we
investigated the relationship between hs-CRP and adiposity
in two widely different populations, one in the African
region and the other in Europe. Most studies that have
explored the CRP-adiposity association used linear models,
which may not appropriately reflect the true underlying
relationship. The aim of this study was to explore the
potential non-linearity of the CRP-adiposity relationship.
For this, we used fractional polynomials—a modeling
technique that allows to flexibly model non linear relations.
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Method
A population-based survey of cardiovascular risk factors
was conducted in 2004 in the Seychelles (Seychelles Heart
Study III) and was attended by 1,255 persons (participation
rate of 80.2%). The sampling frame, methods and main
results of the survey have been described previously [25].
Eighty-six subjects were excluded from the present anal-
ysis because of missing data for the considered variables
and the final sample comprised 1,169 persons (645 women,
524 men). The Ministry of Health approved the survey
after technical and ethical reviews. Participants were free
to participate and gave written informed consent. Current
cigarette smoking was defined as smoking at least one
cigarette per day. Questions on alcohol consumption were
administered only to the participants who reported to have
a drink at least once per month. Alcohol consumption was
assessed by questions on drinking frequency and volume,
which allowed calculating mean ethanol consumption per
day. Physical activity was assessed using the Global
Physical Activity Questionnaire (GPAQ) [26] and MET
equivalent per week was calculated accordingly.
Weight was measured with a validated electronic scale
(Seca) and height with fixed stadiometers (Seca). Body
mass index was calculated as weight (kg) divided by height
(m) squared. Fat mass was measured using a noninvasive
bioimpedance analyzer (Omron body fat monitor HBF-
300). Serum concentration of hs-CRP was measured using
a latex-enforced immunonephelometry using the BN II
(Dade Behring) method.
Regarding the Caucasian population (CoLaus study), the
study population, methods and main results have been
previously described [27]. Briefly, a simple non-stratified
random selection of 19,830 subjects (35% of the source
population) was drawn. Among those eligible, 6,188 per-
sons attended the survey, with a participation rate of 41%.
The study was approved by the Ethics Committee of the
University of Lausanne and participants gave written
informed consent. Sixty-nine subjects were excluded from
the present analysis because of missing data for one or
more of the considered variables. The final sample com-
prised 6,119 persons (3,251 women, 2,937 men). Cigarette
smoking, alcohol consumption and physical activity were
defined for persons who smoked at the time of examina-
tion, drank alcohol at least once a day and had physical
activity of at least 20 min twice a week or more.
Weight was measured to the nearest 0,1 kg using a Seca
scale and height recorded to the nearest 0.5 cm with a Seca
height gauge. Body fat was assessed by electrical bioim-
pedance with the Bodystat 1500 body mass analyzer
(Bodystat Ltd. Isle of Man, UK). Plasma concentration of hs-
CRP was measured by immunoassay and latex HS (maxi-
mum inter- and intra-batch coefficients of variation:
4.6–1.3%, American Laboratory Products Co., Windham,
NH) and leptin by ELISA (12.8–5.8%) (American Labora-
tory Products Co., Windham, NH). HDL cholesterol was
estimated by CHOD-PAP ? PEG ? cyclodextrin (3.6–0.9%,
Roche Diagnostics, CH). Glucose was measured by glucose
dehydrogenase (2.1–1.0%) and insulin estimated by solid-
phase, two-site chemiluminescent immunometric assay
(maximum intra-assay CV of 13.7%, Diagnostic Products
Corporation, Los Angeles, USA). The Homeostasis Model
Assessment (HOMA) score to estimate insulin resistance
was calculated from fasting blood glucose and serum
insulin levels using a standard formula: plasma glucose
(mmol/l) 9 plasma insulin (mU/l)/22.5) [28].
Statistical analysis
We used multivariable fractional polynomials to assess the
best analytical form (i.e. mathematical transformation) of
each continuous regressor included in the regression model
[29]. This modeling technique is particularly useful when
simple mathematical transformations of the explanatory
variable, such as the logarithm or square root, do not allow
linearizing the relation with the outcome (given the other
predictors included in the model) [30]. Very briefly, a
fractional polynomial is a family of mathematical trans-
formations applied to a regressor, which depends on a few
parameters to be estimated by the optimization algorithm.
It includes as special cases the logarithmic, inverse or
square root transformations, but allows for much richer
dose/response profiles. All the analyses were stratified by
gender, as we expected these relations to be different for
men and women. Because of the potential causal role of
hs-CRP on adiposity [21], this factor was considered as the
independent variable of main interest. We considered age-
adjusted, as well as fully-adjusted models (i.e. models
including as regressors age (continuous), smoking (current
or non smoker), alcohol consumption (continuous for
Seychelles Heart Study III and categorical for Colaus) and
physical activity (continuous for Seychelles Heart Study III
and categorical for Colaus), in addition to hs-CRP). Models
with fat mass as the outcome variable were further adjusted
for height. According to Abdullah et al. [31] who described
an independent association between hs-CRP and leptin in
women, models were further adjusted for leptin. For
hs-CRP, we used percentile 95 as cut-off as a robust sta-
tistical approach based on trimming ([9.9 mg/l for men
and [15.2 for women for the Seychelles, [8.1 mg/l for
men and [9.8 for women for Colaus), because the distri-
bution of hs-CRP differs between men and women in
Caucasian and African populations. P values were two-
sided and values less than 0.05 were considered as signif-
icant. Analyses were performed using Stata11.1 software
(Stata Corp., College Station, Texas, USA).
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Results
The baseline characteristics of the Seychelles and Colaus
study participants, stratified by sex, are presented in
Table 1. Overall, in the Seychelles, far less women than
men reported to drink alcohol or to smoke. Women had
higher BMI, fat mass, mean and median hs-CRP levels
than men. By contrast, more Caucasian women smoked or
drank alcohol, and women had lower BMI than men.
Women had higher median leptin and hs-CRP levels than
men.
As the relationship between hs-CRP and adiposity was
similar in age-adjusted models and in fully-adjusted mod-
els (i.e. including age, cigarette smoking, alcohol con-
sumption and physical activity) in both the Caucasian and
African populations, we only present fully-adjusted mod-
els. All covariates included in the models had a linear
relationship with adiposity measures with the exception of
age in African men, in whom the relationship was convex.
The analytical relationship between hs-CRP and fat
mass was clearly different in men and women for both
Caucasian and African descent (Fig. 1). Moreover, the
relationship between hs-CRP and fat mass was non-linear
in both populations (Fig. 1). The increase in fat mass was
markedly larger for low hs-CRP values and then attenuated
at higher hs-CRP levels. At similar hs-CRP values, women
had a higher fat mass than men. However these differences
tended to disappear upon adjustment for leptin (only
available in CoLaus). Results did not change when diabetic
participants were excluded or when adjusting for HDL or
HOMA (results not shown).
The analytical relation between hs-CRP and BMI was
curvilinear in men up to hs-CRP values of 2 mg/l and then
linear with 0 slope. In women, the relation between BMI
and hs-CRP was curvilinear for low CRP levels and linear
thereafter, but with a non null slope, in both populations
(Fig. 1). We observed that African women had notably
higher BMI than men, whereas this was not the case for
Caucasians. For the same BMI, Caucasian women tended
to have higher hs-CRP values than African women
(Table 2).
Discussion
As expected, we found that the dose/response analytical
relation between hs-CRP and adiposity differed in men and
women in both the Caucasian and African populations. The
present study also yielded novel findings. First, the ana-
lytical relationship between hs-CRP and adiposity was non-
linear. Second, this pattern of association was consistent
across two ethnically different populations living in widely
different environments. Finally, the sex difference in the
relation between adiposity and hs-CRP was strongly
attenuated upon adjustment for leptin.
Many studies have addressed sex differences in the
relationship between hs-CRP and adiposity [14, 16–20] and
have shown that correlations are stronger in women than
men. However, most of them used linear models, which
may not accurately reflect the true relation between hs-CRP
and adiposity. The sex difference in the relationship
between hs-CRP and adiposity seems to rely on different
Table 1 Participants’ characteristics by sex and study population
CoLaus study (Caucasians) Seychelles’ study (Africans)
Men Women Men Women
n 2,906 3,213 524 645
Age (year) 52.6 (10.8) 53.5 (10.7) 45.2 (10.9) 44.8 (11.2)
Height (cm) 175.0 (7.3) 162.7 (6.7) 171.7 (7.0) 159.9 (6.3)
Weight (kg) 81.5 (13.3) 66.4 (12.9) 75.8 (15.3) 73.6 (16.4)
BMI (kg/m2) 26.6 (4.0) 25.1 (4.9) 25.9 (4.7) 28.7 (6.1)
Fat mass (kg) 19.8 (7.6) 23.4 (9.5) 15.6 (7.3) 25.6 (10.1)
hs-CRP (mg/l) 1.2 (0.6–2.6) 1.3 (0.6–2.9) 1.4 (0.7–2.9) 2.3 (1.1–5.3)
Leptin (ng/ml) 6.4 (3.9–10.8) 14 (8.2–23.0)
Alcohola 1,034 (35.6) 488 (15.2) 15.8 (0–50.8) 0 (0–0)
Current smokers (%) 852 (29.3) 802 (25.0) 160 (30.5) 22 (3.41)
Physical activity 1,556 (53.5) 1,841 (57.3) 2,520 (900–5,640) 2,370 (900–4,320)
Results are presented as mean with SD or median with interquartile range or as number of subjects and percentage
Physical activity is defined as number of persons with regular physical activity (at least 20 min twice a week) in Colaus, as median MET of
physical activity per week for the Seychelles
a Alcohol is defined as number (%) of regular alcohol drinkers (at least once a day) in Colaus, as median quantity with interquartile range per day
in ml for the Seychelles
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endocrine function of the adipose tissue, in women vs.
men, and corresponding different production of cytokines
and hormones that may increase hs-CRP levels. Indeed,
one third of interleukin-6 is produced in the adipose tissue
and is involved in hs-CRP release from the liver [32, 33].
Another hypothesis is linked to the sex difference in leptin
levels. In women, Abdullah et al. [31] described strong
independent correlations between adiposity and leptin, on
one hand, and between leptin and hs-CRP, on the other
hand. Samara et al. [34] found a significant positive rela-
tion between leptin and CRP in women but not in men,
using a model in which fat mass, among others, was
included as a covariate. Our findings illustrated that sex
difference in the relationship between hs-CRP and fat mass
nearly disappeared upon adjustment with leptin, suggesting
that leptin may mediate sex-related differences in the
relationship between hs-CRP and fat mass. Plasma leptin
levels are higher in women than men and a direct action of
leptin on hs-CRP has been suggested [21, 35, 36]. More-
over, experimental evidence shows that leptin administra-
tion increases hs-CRP levels in humans [37]. It has also
been suggested that the relationship between adiposity and
hs-CRP is consistent across different ethnic groups [14, 17,
18]. Our study extends these findings to two ethnically
different populations (Africans and Caucasians) living in
different settings (Seychelles and Switzerland).
There are some limitations to this study. First, our
results on the role of leptin, may not apply to non-Cauca-
sians since leptin was measured only in the CoLaus study.
Second, we could not adjust for statin and estrogen use in
the Seychelles study. However, almost identical findings in
these two different populations suggest that adjustments for
Fig. 1 Comparison of the relationship of hs-CRP with fat mass and
BMI stratified by sex in CoLaus and the Seychelles’ study Scatter-
plots of hs-CRP versus fat mass or body mass index by sex in the
CoLaus study and in the Seychelles’ study. Fractional polynomials
are adjusted for age, cigarette smoking, alcohol consumption and
physical activity. a Relationship between hs-CRP and fat mass in the
Seychelles. b Relationship between hs-CRP and fat mass in the
CoLaus study. c Relationship between hs-CRP and fat mass in the
CoLaus study, with additional adjustment for leptin. d Relationship
between hs-CRP and body mass index in the Seychelles’ study.
e Relationship between hs-CRP and body mass index in the CoLaus
study
Table 2 Median hs-CRP according to body mass index and sex in
the CoLaus study and in the Seychelles’ study
BMI class (kg/m2)
Median hs-CRP (mg/l) \25 25 to \30 30
Women CoLaus 0.8 1.9 3.8
Women Seychelles 1.6 2.1 4.1
Men CoLaus 0.8 1.4 2.1
Men Seychelles 1.0 1.65 1.9
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these factors would not have had substantial impact.
Strengths of the study are the use of a non-linear dose/
response relation between hs-CRP and the outcome that
better and more realistically fits the data, the availability of
data in two populations that have different ethnic back-
ground and live in completely different environments, and
the population-based design of both studies, which
increases the external validity of the findings. Also, we
acknowledge that other regression models for handling non
linearity would have likely yielded similar results.
In conclusion, we report a non-linear relation between
hs-CRP and adiposity. This mathematical relation was
steeper in women than men, in particular at low hs-CRP
levels. Furthermore, our findings suggest that the sex dif-
ference in the relationship between adiposity and CRP
might be mediated by leptin. Additional research is needed
to further elucidate the mechanisms behind these findings.
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